Verily is the famous Corporate Investor, which was founded in 2015. The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the San Francisco.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Personal Health, Fitness. Among the most popular portfolio startups of the fund, we may highlight Oscar Health Insurance Co., Freenome, Culture Biosciences. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.
The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 50 - 100 millions dollars. This Verily works on 15 percentage points less the average amount of lead investments comparing to the other organizations. The average startup value when the investment from Verily is more than 1 billion dollars. The increased amount of exits for fund were in 2019. The important activity for fund was in 2019.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Verily, startups are often financed by Founders Fund, Andreessen Horowitz, Dolby Family Ventures. The meaningful sponsors for the fund in investment in the same round are Section 32, Andreessen Horowitz, Uncommon Denominator. In the next rounds fund is usually obtained by Section 32, Uncommon Denominator, T. Rowe Price.
|Boston University||Boston, Massachusetts, United States|
|GGR Capital||Beijing, Beijing, China|
|Growth Capital Ventures||England, London, United Kingdom|
|Harvest Investments||Chicago, Illinois, United States|
|Huachuang Securities||China, Guiyang, Guizhou|
|Lemnos VC||California, San Francisco, United States|
|Mahindra Rise||India, Maharashtra, Mumbai|
|NITTO KOGYO||Chiyoda, Japan|
|Outland Group||Canada, Ontario, Toronto|
|Premiere Capital||Brighton, East Sussex, United Kingdom|
|Razor's Edge Ventures||Reston, United States, Virginia|
|Redianchang Touzi||China, Hangzhou, Zhejiang|
|Sachem Ventures||Connecticut, New Haven, United States|
|Stingray||Canada, Montréal, Quebec|
|Symbiotics Group||Geneva, Geneve, Switzerland|
|Techstars Sustainability, in partnership with The Nature Conservancy||Colorado, Denver, United States|
|The Keffi Group||New York, New York, United States|
|transcosmos inc||Japan, Kanagawa Prefecture, Kawasaki|
|Vanenburg Group||Gelderland, Putten, The Netherlands|
|VersoVentures||Finland, Helsinki, Southern Finland|
The Public Health Company
|$35M||01 May 2022||California, United States|
|$1B||17 Dec 2021||Cambridge, Massachusetts, United States|
|$80M||14 Oct 2021||San Francisco, California, United States|
|$4M||11 May 2021||San Marino, California, United States|
|$8M||29 Apr 2021||California, United States|
|$50M||11 Jan 2021||San Diego, California, United States|
|$15M||04 Mar 2020||San Francisco, California, United States|
|$45M||30 Jan 2020||San Francisco, California, United States|
|$160M||24 Jul 2019||South San Francisco, California, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.